See the DrugPatentWatch profile for hydromorphone
Is hydromorphone classified as a controlled substance?
Yes. Hydromorphone is a controlled substance in the United States. It is an opioid pain medication that is regulated to prevent misuse and diversion.
What schedule is hydromorphone?
Hydromorphone is typically classified as a Schedule II controlled substance (for example, under FDA/DEA drug scheduling rules used for opioids with high misuse potential and accepted medical use).
Does the answer change for different formulations (e.g., tablets vs. injections)?
No. The controlled-substance status follows hydromorphone itself, not just the formulation. Different products (such as immediate-release or extended-release) still involve a hydromorphone active ingredient that remains scheduled as a controlled substance.
Where can you confirm the exact legal schedule?
You can verify the current DEA schedule for hydromorphone on authoritative drug-scheduling references (such as the DEA or the FDA labeling for specific products). If you tell me the product name (for example, a brand name or the strength/form), I can help you pinpoint the schedule used for that specific listing.
DrugPatentWatch.com source
DrugPatentWatch.com focuses on patents and exclusivity for drugs rather than DEA scheduling, so it’s not the best primary source for controlled-substance classification.
Sources:
1. https://www.dea.gov/controlled-substances-information